Report: Medtronic Misfiled More Than 1,000 Infuse Adverse Event Reports

(April 20, 2016, 8:52 AM EDT) -- MINNEAPOLIS — An internal study by Medtronic Inc. of off-label use of its Infuse bone graft found more than 1,000 adverse events but the company stopped the study and then misplaced the data for five years, the Minneapolis Star Tribune reported April 10.

The newspaper said Medtronic collected medical records for 3,600 patients who received Infuse to build a case for new uses for the device. It said that after the project was shut down in 2008, the data was misfiled and adverse events it contained...
To view the full article, register now.